PT-141 peptide side effects include nausea, flushing, and headache. Learn how long they last, who should avoid bremelanotide, and when to call a doctor.
PT-141 (bremelanotide) is a prescription melanocortin receptor agonist approved as an injection for hypoactive sexual desire disorder (HSDD) in premenopausal women. The most commonly reported PT-141 peptide side effects are nausea, flushing, headache, and injection site reactions, and most of these are mild to moderate and fade within a few hours. Serious reactions are uncommon but include temporary blood pressure increases and skin darkening with repeated use.
What Is PT-141 and How Is It Used?
PT-141 is the research name for bremelanotide, sold under the brand name Vyleesi. The FDA approved the injectable form in 2019 for premenopausal women with acquired, generalized HSDD. Bremelanotide is FDA-approved only for that population; it is not approved for men, and the injectable is the only approved form.
Bremelanotide works by activating melanocortin receptors in the brain, a pathway involved in sexual desire. It is typically injected subcutaneously into the abdomen or thigh at least 45 minutes before anticipated sexual activity, with a maximum of one dose in 24 hours and no more than eight doses per month.
Because PT-141 is a prescription drug, any use outside the approved label — including compounded vials, nasal sprays, and use by men — is off-label. Off-label use raises the risk of dosing errors and unmonitored side effects.
Most Common PT-141 Peptide Side Effects
Clinical trials tracked side effects in thousands of women. The table below summarizes the rates reported in the pivotal trials along with typical duration.
| Side Effect | Reported Rate | Typical Duration |
|---|---|---|
| Nausea | About 40% | 1–3 hours |
| Flushing | About 20% | 30 minutes–2 hours |
| Headache | About 11% | 1–4 hours |
| Injection site reactions | About 13% | 1–2 days |
| Vomiting | About 5% | A few hours |
Other effects reported in trials include fatigue, dizziness, hot flashes, and mild increases in blood pressure. Most people who experience nausea describe it as mild, and it often lessens with later doses.
Key point: Bremelanotide is not FDA-approved for men or as a nasal spray, so any product marketed that way is unregulated.
How Long Do PT-141 Side Effects Last?
Side effects usually begin within 15 to 60 minutes of injection and peak around the one-hour mark. Most resolve within two to four hours, which is roughly the drug's active window.
Nausea and headache can linger longer in some people, especially at higher doses or when the drug is taken without food. Injection site reactions, such as redness or bruising, may last a day or two.
Persistent nausea that prevents eating or drinking, or a headache that does not respond to over-the-counter pain relievers, is a reason to contact a healthcare professional.
Serious Side Effects and Warnings
Serious reactions are rare but documented. The most notable are transient increases in blood pressure and focal hyperpigmentation — dark patches on the skin, gums, or face — that can appear after repeated use.
- Blood pressure elevation: PT-141 can raise blood pressure for several hours, and it is contraindicated in people with uncontrolled hypertension or known cardiovascular disease.
- Focal hyperpigmentation: Darkening of the skin, gums, or genital area has been reported with regular use, and it may not fully reverse after stopping.
- Severe nausea or vomiting: A small number of users stop treatment because of gastrointestinal effects.
- Allergic reactions: Rash, itching, or swelling warrants immediate medical attention.
PT-141 Nasal Spray and Other Delivery Methods
An older nasal spray version of bremelanotide was studied and then discontinued after it produced higher rates of blood pressure elevation than the injection. That history helps explain why clinicians track pt-141 peptide nasal spray side effects separately from the injectable form.
Many people who search for pt 141 peptide side effects are actually looking for the injectable product and end up on sites selling sprays. Compounded nasal sprays sold online are not FDA-approved, are not required to meet the same purity standards, and may deliver inconsistent doses.
Reported nasal effects include irritation, congestion, nosebleeds, and a bitter taste, on top of the systemic effects listed above. People exploring research peptides sometimes review ss-31 peptide benefits and side effects when studying mitochondrial-targeted compounds, and others examine vip peptide side effects when evaluating vasoactive intestinal peptide. Those are different molecules with different risk profiles, and neither is a substitute for PT-141.
PT-141 Side Effects in Women and Men
Most published safety data come from premenopausal women, because that is the approved population. Reported pt-141 for women side effects mirror the trial data: nausea, flushing, headache, and injection site reactions are the leading complaints.
Men have used PT-141 off-label for erectile function, but the evidence base is much smaller. Available reports suggest a similar side effect profile, with nausea and flushing being most common.
Alcohol can worsen nausea, flushing, and dizziness, so combining it with PT-141 is generally discouraged.
Who Should Avoid PT-141?
PT-141 is not appropriate for everyone. Talk with a healthcare professional before using it if any of the following apply:
- Uncontrolled high blood pressure or a history of cardiovascular disease
- Current use of blood pressure medications or nitrates
- Pregnancy or breastfeeding
- Kidney or liver impairment
- A history of melanoma or skin pigmentation disorders
PT-141 should not be used more than once in 24 hours or more than eight times per month. Exceeding the recommended dose increases the chance of nausea, vomiting, and blood pressure changes.
When to Talk to a Doctor
Mild nausea, flushing, or a headache after an injection is common and usually not dangerous. Seek medical care if you experience chest pain, a severe headache, vision changes, swelling, or a blood pressure reading that stays high.
Because PT-141 affects blood pressure and pigmentation, regular monitoring is reasonable for anyone using it long term. A healthcare professional can help weigh the benefits against the risks and adjust or stop treatment if needed.
Frequently Asked Questions
What are the most common side effects of PT-141?
The most frequently reported side effects are nausea (about 40% of users in trials), flushing (about 20%), headache (about 11%), and injection site reactions (about 13%). Vomiting, fatigue, dizziness, and hot flashes are less common. Most of these effects are mild to moderate and resolve within a few hours.
How long do PT-141 side effects last?
Side effects typically start within 15 to 60 minutes of injection, peak around one hour, and clear within two to four hours. Nausea and headaches can occasionally last longer. Injection site redness or bruising may take a day or two to fade.
Does PT-141 cause long-term side effects?
The main long-term concern is focal hyperpigmentation, or dark patches on the skin, gums, or face, which has been reported with repeated use and may not fully reverse after stopping. Blood pressure increases are usually temporary but should be monitored. Long-term safety data are limited, so anyone using PT-141 regularly should stay in contact with a healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.